Lyell Immunopharma News

Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

Aug 7 22:19 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

Aug 7 16:13 ET

Lyell Immunopharma | 8-K: Current report

Jun 26 08:38 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Jun 17 16:45 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Klausner Richard

Jun 17 16:24 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director Bishop Hans Edgar

Jun 17 16:23 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL

Jun 17 16:19 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director NABEL ELIZABETH G

Jun 17 16:13 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director BRAWLEY OTIS W

Jun 17 16:11 ET

Lyell Immunopharma | 4: Statement of changes in beneficial ownership of securities-Director FRIEDMAN CATHY

Jun 17 16:11 ET

Lyell Immunopharma | 8-K: Current report

Jun 14 16:29 ET

Lyell Immunopharma | 424B5: Prospectus

May 6 08:14 ET

Lyell Immunopharma | 10-Q: Q1 2024 Earnings Report

May 6 08:09 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

May 6 08:03 ET

Lyell Immunopharma | EFFECT: Others

May 6 06:18 ET

Lyell Immunopharma | CORRESP: CORRESP

May 1 22:22 ET

Lyell Immunopharma | ARS: Annual Report to Security Holders

Apr 22 16:22 ET

Lyell Immunopharma | DEFA14A: Others

Apr 22 16:22 ET

Lyell Immunopharma | DEF 14A: Definitive information statements

Apr 22 16:17 ET

Lyell Immunopharma | UPLOAD: Others

Mar 4 22:16 ET